Characterization of WZ4003 and HTH-01-015 as selective inhibitors of the LKB1-tumour-suppressor-activated NUAK kinases. (2014)
Attributed to:
A systematic investigation into the pathogenesis and course of Parkinson's syndrome
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1042/bj20131152
PubMed Identifier: 24171924
Publication URI: http://europepmc.org/abstract/MED/24171924
Type: Journal Article/Review
Volume: 457
Parent Publication: The Biochemical journal
Issue: 1
ISSN: 0264-6021